Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.07 | 0.2 |
mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.2 |
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |